0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Real-World Evidence in Healthcare Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-22O13868
Home | Market Reports | Health| Nursing
Global Real World Evidence in Healthcare Market Research Report 2023
BUY CHAPTERS

Global Real-World Evidence in Healthcare Market Research Report 2025

Code: QYRE-Auto-22O13868
Report
April 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Real-World Evidence in Healthcare Market Size

The global market for Real-World Evidence in Healthcare was valued at US$ 466 million in the year 2024 and is projected to reach a revised size of US$ 803 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Real-World Evidence in Healthcare Market

Real-World Evidence in Healthcare Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Real-World Evidence in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-World Evidence in Healthcare.
The Real-World Evidence in Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Real-World Evidence in Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Real-World Evidence in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Real-World Evidence in Healthcare Market Report

Report Metric Details
Report Name Real-World Evidence in Healthcare Market
Accounted market size in year US$ 466 million
Forecasted market size in 2031 US$ 803 million
CAGR 8.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Service
  • Data Set
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Anthem, IQVIA, ICON, PPD, Clinigen Group, Cognizant Technology Solutions Corporation, Oracle, Parexel, PerkinElmer, SAS Institute, UnitedHealth Group, Flatiron Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Real-World Evidence in Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Real-World Evidence in Healthcare Market growing?

Ans: The Real-World Evidence in Healthcare Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Real-World Evidence in Healthcare Market size in 2031?

Ans: The Real-World Evidence in Healthcare Market size in 2031 will be US$ 803 million.

Who are the main players in the Real-World Evidence in Healthcare Market report?

Ans: The main players in the Real-World Evidence in Healthcare Market are Anthem, IQVIA, ICON, PPD, Clinigen Group, Cognizant Technology Solutions Corporation, Oracle, Parexel, PerkinElmer, SAS Institute, UnitedHealth Group, Flatiron Health

What are the Application segmentation covered in the Real-World Evidence in Healthcare Market report?

Ans: The Applications covered in the Real-World Evidence in Healthcare Market report are Drug Development and Approval, Development and Approval of Medical Devices

What are the Type segmentation covered in the Real-World Evidence in Healthcare Market report?

Ans: The Types covered in the Real-World Evidence in Healthcare Market report are Service, Data Set

Recommended Reports

Medical Devices & Equipment

Medical Technology & Imaging

Healthcare Services & Data

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-World Evidence in Healthcare Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Service
1.2.3 Data Set
1.3 Market by Application
1.3.1 Global Real-World Evidence in Healthcare Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development and Approval
1.3.3 Development and Approval of Medical Devices
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-World Evidence in Healthcare Market Perspective (2020-2031)
2.2 Global Real-World Evidence in Healthcare Growth Trends by Region
2.2.1 Global Real-World Evidence in Healthcare Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Real-World Evidence in Healthcare Historic Market Size by Region (2020-2025)
2.2.3 Real-World Evidence in Healthcare Forecasted Market Size by Region (2026-2031)
2.3 Real-World Evidence in Healthcare Market Dynamics
2.3.1 Real-World Evidence in Healthcare Industry Trends
2.3.2 Real-World Evidence in Healthcare Market Drivers
2.3.3 Real-World Evidence in Healthcare Market Challenges
2.3.4 Real-World Evidence in Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-World Evidence in Healthcare Players by Revenue
3.1.1 Global Top Real-World Evidence in Healthcare Players by Revenue (2020-2025)
3.1.2 Global Real-World Evidence in Healthcare Revenue Market Share by Players (2020-2025)
3.2 Global Real-World Evidence in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Real-World Evidence in Healthcare Revenue
3.4 Global Real-World Evidence in Healthcare Market Concentration Ratio
3.4.1 Global Real-World Evidence in Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-World Evidence in Healthcare Revenue in 2024
3.5 Global Key Players of Real-World Evidence in Healthcare Head office and Area Served
3.6 Global Key Players of Real-World Evidence in Healthcare, Product and Application
3.7 Global Key Players of Real-World Evidence in Healthcare, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-World Evidence in Healthcare Breakdown Data by Type
4.1 Global Real-World Evidence in Healthcare Historic Market Size by Type (2020-2025)
4.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2026-2031)
5 Real-World Evidence in Healthcare Breakdown Data by Application
5.1 Global Real-World Evidence in Healthcare Historic Market Size by Application (2020-2025)
5.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Real-World Evidence in Healthcare Market Size (2020-2031)
6.2 North America Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Real-World Evidence in Healthcare Market Size by Country (2020-2025)
6.4 North America Real-World Evidence in Healthcare Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-World Evidence in Healthcare Market Size (2020-2031)
7.2 Europe Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Real-World Evidence in Healthcare Market Size by Country (2020-2025)
7.4 Europe Real-World Evidence in Healthcare Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-World Evidence in Healthcare Market Size (2020-2031)
8.2 Asia-Pacific Real-World Evidence in Healthcare Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2020-2025)
8.4 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-World Evidence in Healthcare Market Size (2020-2031)
9.2 Latin America Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Real-World Evidence in Healthcare Market Size by Country (2020-2025)
9.4 Latin America Real-World Evidence in Healthcare Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-World Evidence in Healthcare Market Size (2020-2031)
10.2 Middle East & Africa Real-World Evidence in Healthcare Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2020-2025)
10.4 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthem
11.1.1 Anthem Company Details
11.1.2 Anthem Business Overview
11.1.3 Anthem Real-World Evidence in Healthcare Introduction
11.1.4 Anthem Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.1.5 Anthem Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Real-World Evidence in Healthcare Introduction
11.2.4 IQVIA Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.2.5 IQVIA Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Real-World Evidence in Healthcare Introduction
11.3.4 ICON Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.3.5 ICON Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Real-World Evidence in Healthcare Introduction
11.4.4 PPD Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.4.5 PPD Recent Development
11.5 Clinigen Group
11.5.1 Clinigen Group Company Details
11.5.2 Clinigen Group Business Overview
11.5.3 Clinigen Group Real-World Evidence in Healthcare Introduction
11.5.4 Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.5.5 Clinigen Group Recent Development
11.6 Cognizant Technology Solutions Corporation
11.6.1 Cognizant Technology Solutions Corporation Company Details
11.6.2 Cognizant Technology Solutions Corporation Business Overview
11.6.3 Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Introduction
11.6.4 Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.6.5 Cognizant Technology Solutions Corporation Recent Development
11.7 Oracle
11.7.1 Oracle Company Details
11.7.2 Oracle Business Overview
11.7.3 Oracle Real-World Evidence in Healthcare Introduction
11.7.4 Oracle Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.7.5 Oracle Recent Development
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Real-World Evidence in Healthcare Introduction
11.8.4 Parexel Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.8.5 Parexel Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Real-World Evidence in Healthcare Introduction
11.9.4 PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.9.5 PerkinElmer Recent Development
11.10 SAS Institute
11.10.1 SAS Institute Company Details
11.10.2 SAS Institute Business Overview
11.10.3 SAS Institute Real-World Evidence in Healthcare Introduction
11.10.4 SAS Institute Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.10.5 SAS Institute Recent Development
11.11 UnitedHealth Group
11.11.1 UnitedHealth Group Company Details
11.11.2 UnitedHealth Group Business Overview
11.11.3 UnitedHealth Group Real-World Evidence in Healthcare Introduction
11.11.4 UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.11.5 UnitedHealth Group Recent Development
11.12 Flatiron Health
11.12.1 Flatiron Health Company Details
11.12.2 Flatiron Health Business Overview
11.12.3 Flatiron Health Real-World Evidence in Healthcare Introduction
11.12.4 Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2020-2025)
11.12.5 Flatiron Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Real-World Evidence in Healthcare Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Service
 Table 3. Key Players of Data Set
 Table 4. Global Real-World Evidence in Healthcare Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Real-World Evidence in Healthcare Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Real-World Evidence in Healthcare Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Real-World Evidence in Healthcare Market Share by Region (2020-2025)
 Table 8. Global Real-World Evidence in Healthcare Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Real-World Evidence in Healthcare Market Share by Region (2026-2031)
 Table 10. Real-World Evidence in Healthcare Market Trends
 Table 11. Real-World Evidence in Healthcare Market Drivers
 Table 12. Real-World Evidence in Healthcare Market Challenges
 Table 13. Real-World Evidence in Healthcare Market Restraints
 Table 14. Global Real-World Evidence in Healthcare Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Real-World Evidence in Healthcare Market Share by Players (2020-2025)
 Table 16. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2024)
 Table 17. Ranking of Global Top Real-World Evidence in Healthcare Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Real-World Evidence in Healthcare Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Real-World Evidence in Healthcare, Headquarters and Area Served
 Table 20. Global Key Players of Real-World Evidence in Healthcare, Product and Application
 Table 21. Global Key Players of Real-World Evidence in Healthcare, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Real-World Evidence in Healthcare Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2020-2025)
 Table 25. Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2026-2031)
 Table 27. Global Real-World Evidence in Healthcare Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2020-2025)
 Table 29. Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2026-2031)
 Table 31. North America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Real-World Evidence in Healthcare Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Anthem Company Details
 Table 47. Anthem Business Overview
 Table 48. Anthem Real-World Evidence in Healthcare Product
 Table 49. Anthem Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 50. Anthem Recent Development
 Table 51. IQVIA Company Details
 Table 52. IQVIA Business Overview
 Table 53. IQVIA Real-World Evidence in Healthcare Product
 Table 54. IQVIA Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 55. IQVIA Recent Development
 Table 56. ICON Company Details
 Table 57. ICON Business Overview
 Table 58. ICON Real-World Evidence in Healthcare Product
 Table 59. ICON Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 60. ICON Recent Development
 Table 61. PPD Company Details
 Table 62. PPD Business Overview
 Table 63. PPD Real-World Evidence in Healthcare Product
 Table 64. PPD Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 65. PPD Recent Development
 Table 66. Clinigen Group Company Details
 Table 67. Clinigen Group Business Overview
 Table 68. Clinigen Group Real-World Evidence in Healthcare Product
 Table 69. Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 70. Clinigen Group Recent Development
 Table 71. Cognizant Technology Solutions Corporation Company Details
 Table 72. Cognizant Technology Solutions Corporation Business Overview
 Table 73. Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Product
 Table 74. Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 75. Cognizant Technology Solutions Corporation Recent Development
 Table 76. Oracle Company Details
 Table 77. Oracle Business Overview
 Table 78. Oracle Real-World Evidence in Healthcare Product
 Table 79. Oracle Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 80. Oracle Recent Development
 Table 81. Parexel Company Details
 Table 82. Parexel Business Overview
 Table 83. Parexel Real-World Evidence in Healthcare Product
 Table 84. Parexel Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 85. Parexel Recent Development
 Table 86. PerkinElmer Company Details
 Table 87. PerkinElmer Business Overview
 Table 88. PerkinElmer Real-World Evidence in Healthcare Product
 Table 89. PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 90. PerkinElmer Recent Development
 Table 91. SAS Institute Company Details
 Table 92. SAS Institute Business Overview
 Table 93. SAS Institute Real-World Evidence in Healthcare Product
 Table 94. SAS Institute Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 95. SAS Institute Recent Development
 Table 96. UnitedHealth Group Company Details
 Table 97. UnitedHealth Group Business Overview
 Table 98. UnitedHealth Group Real-World Evidence in Healthcare Product
 Table 99. UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 100. UnitedHealth Group Recent Development
 Table 101. Flatiron Health Company Details
 Table 102. Flatiron Health Business Overview
 Table 103. Flatiron Health Real-World Evidence in Healthcare Product
 Table 104. Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2020-2025) & (US$ Million)
 Table 105. Flatiron Health Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Real-World Evidence in Healthcare Picture
 Figure 2. Global Real-World Evidence in Healthcare Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Real-World Evidence in Healthcare Market Share by Type: 2024 VS 2031
 Figure 4. Service Features
 Figure 5. Data Set Features
 Figure 6. Global Real-World Evidence in Healthcare Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Real-World Evidence in Healthcare Market Share by Application: 2024 VS 2031
 Figure 8. Drug Development and Approval Case Studies
 Figure 9. Development and Approval of Medical Devices Case Studies
 Figure 10. Real-World Evidence in Healthcare Report Years Considered
 Figure 11. Global Real-World Evidence in Healthcare Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Real-World Evidence in Healthcare Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Real-World Evidence in Healthcare Market Share by Region: 2024 VS 2031
 Figure 14. Global Real-World Evidence in Healthcare Market Share by Players in 2024
 Figure 15. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Real-World Evidence in Healthcare Revenue in 2024
 Figure 17. North America Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Real-World Evidence in Healthcare Market Share by Country (2020-2031)
 Figure 19. United States Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Real-World Evidence in Healthcare Market Share by Country (2020-2031)
 Figure 23. Germany Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Real-World Evidence in Healthcare Market Share by Region (2020-2031)
 Figure 31. China Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Real-World Evidence in Healthcare Market Share by Country (2020-2031)
 Figure 39. Mexico Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Real-World Evidence in Healthcare Market Share by Country (2020-2031)
 Figure 43. Turkey Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Real-World Evidence in Healthcare Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Anthem Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 47. IQVIA Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 48. ICON Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 49. PPD Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 50. Clinigen Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 51. Cognizant Technology Solutions Corporation Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 52. Oracle Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 53. Parexel Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 54. PerkinElmer Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 55. SAS Institute Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 56. UnitedHealth Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 57. Flatiron Health Revenue Growth Rate in Real-World Evidence in Healthcare Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Ultrasonics Technologies Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0L6392
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Health Self-monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4V7252
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global High-Acuity Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4O6282
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Marburgvirus Infection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36D6023
Mon Sep 08 00:00:00 UTC 2025

Add to Cart